Kindred Biosciences
KIN
#7030
Rank
NZ$0.74 B
Marketcap
$16.36
Share price
0.11%
Change (1 day)
N/A
Change (1 year)

Revenue for Kindred Biosciences (KIN)

Revenue in 2021 (TTM): NZ$11.38 Million

According to Kindred Biosciences 's latest financial reports the company's current revenue is NZ$14.01 Million. In 2020 the company made a revenue of NZ$74.61 Million an increase over the revenue in the year 2019 that were of NZ$7.57 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Kindred Biosciences from 2019 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)NZ$11.38 M-84.74%
2020NZ$74.61 M885.15%
2019NZ$7.57 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$16.18 B 115,368.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$111.73 B 796,947.69%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$72.27 B 515,460.18%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.85 B 13,106.69%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.00 B 78,395.29%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.45 B 3,115.85%๐Ÿ‡บ๐Ÿ‡ธ USA